Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.
Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Cairns NJ, Ghetti B, Spina S, Garbern J, Tselis AC, Uitti R, Das P, Van Gerpen JA, Meschia JF, Levy S, Broderick DF, Graff-Radford N, Ross OA, Miller BB, Swerdlow RH, Dickson DW, Wszolek ZK. Rademakers R, et al. Among authors: tselis ac. Nat Genet. 2011 Dec 25;44(2):200-5. doi: 10.1038/ng.1027. Nat Genet. 2011. PMID: 22197934 Free PMC article.
A prospective, open-label treatment trial to compare the effect of IFNbeta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing--remitting multiple sclerosis: results after 18 months of therapy.
Khan OA, Tselis AC, Kamholz JA, Garbern JY, Lewis RA, Lisak RP. Khan OA, et al. Among authors: tselis ac. Mult Scler. 2001 Dec;7(6):349-53. doi: 10.1177/135245850100700601. Mult Scler. 2001. PMID: 11795454 Clinical Trial.
Glatiramer acetate therapy for multiple sclerosis: a review.
Perumal J, Filippi M, Ford C, Johnson K, Lisak R, Metz L, Tselis A, Tullman M, Khan O. Perumal J, et al. Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):1019-29. doi: 10.1517/17425255.2.6.1019. Expert Opin Drug Metab Toxicol. 2006. PMID: 17125414 Review.
Multiple sclerosis: therapeutic update.
Tselis AC, Lisak RP. Tselis AC, et al. Arch Neurol. 1999 Mar;56(3):277-80. doi: 10.1001/archneur.56.3.277. Arch Neurol. 1999. PMID: 10190816 Review.
53 results